DatasetName,NAF1_S(258),NAF1_S(184) NAF1_S(315) NAF1_Y(252)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.4844232333185457
SR2019_MCF7_Biol_repl_3,,0.49084439821351405
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5049854221634098
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5208374424795954
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.4972685342001424
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5161998426576838
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,0.4986011106133031
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.4975099667186635
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.545639227965581
WZ2023_Pu_010_30min,,0.5833878324077854
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5676685009907799
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5879412222955627
JJ2018_Ratio H/L normalized___1,,0.48903962742849405
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.5108876660333884
AH2018_SILAC_MR_2_N,,0.5495838910497634
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.4714660962357717
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.4991209573695658
UK2020_HCM_2,,0.5287662658835135
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.48712033837366703
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5531980681974022
RB2022_2_PreSprint,,0.5639350333304978
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5868856920094236
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,0.5894922020011667
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5203907137951366
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,0.5878522136185166
AH2018_SILAC_MR_2_X,,0.5641040557429425
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.504819907223356
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5244086268371155
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.5022109966399101
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.513255613251277
JJ2018_Ratio M/L normalized pP3,,0.5072463790815737
AH2018_SILAC_M_2_N,,0.5151045280792308
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.510116625794765
AH2018_LFQ_1_C,,0.5556070408822796
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.5858778652425158
CK2022_11 40-1,,0.5195336510660739
CW2012_10 µM Erl/control Experiment 3 Replicate B,,0.5330199903421563
AH2018_SILAC_2_X,,0.5138659505225237
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5563770164559104
FSO2013_Ratio H/L normalized Rep2,,0.5104671449793053
WZ2023_Pu_005_20min,,0.5815428463526863
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5248919937902358
CW2012_10 µM Gef/control Experiment 2 Replicate B,,0.5045790288349467
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5619573866274535
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.4837458615273486
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.5264113759377677
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5217959305389549
CK2022_1 200-1,,0.543035417416651
PG2020_Intensity Mock_10h_D,,0.47574298584300934
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,0.549837504710088
RB2022_6_RecoveryEndurance,,0.5711719459789233
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.48125284537584
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5119495490635072
PG2020_Intensity 2h_C,,0.5157257863649293
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5719465480764201
CK2022_3 40-1,,0.5366904170210601
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5431529585932756
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5738072047464453
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,0.4699882662723965
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5146804331328084
YA2020_Reporter_intensity_Normal_No.1,,0.5361009453296384
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.5459829275636379
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5491717279089537
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5238899275125242
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5411789724147568
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,0.47700615536529617
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.5891847691359069
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5357486726518133
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.5073165932488558
KS2014_Intensity N3,,0.54323774537588
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5226560663462487
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.5149870884778641
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.496839473074892
KS2014_Intensity E15_2,,0.558330316630033
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5294927830458332
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.466109358580507
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5139834428978988
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5408033772127429
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.5472143968171204
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,0.4831247669260979
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5486437507661388
AH2018_SILAC_IT_3_X,,0.49615385183767025
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5155292613082029
FSO2013_Ratio M/L normalized Rep2,,0.475542536131404
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,0.47668878937395903
CK2022_14 40-1,,0.5101424222771911
RB2022_6_PreSprint,,0.5794943157772622
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5490792975304505
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5226680375125686
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5016665195724682
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.49060665710350376
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5224828451321891
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5261995495136734
JW2021_After_3,,
GF2025_P8_Sph,,0.5521838706769563
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5141499786132728
CK2022_11 200-1,,0.522547211014385
CK2022_12 200-1,,0.5080441329543869
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,0.5818150863944664
AH2018_TMTMS2_2_N,,0.5925760574230042
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.5686318536018043
KS2014_Intensity N4,,0.5304249928534701
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.46208402279870037
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.523744454270357
CK2022_14 200-1,,0.5178036721967759
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5302773799193118
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5629623954235695
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.5246264817557481
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.49281627967944197
GF2025_P1_Adh,,0.4921530613305663
GF2025_P1_Sph,,0.5406439330392756
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5917203010074413
CF2017_EOC 1,,0.5052291297195612
CK2022_3 200-1,,0.5429495586124625
AH2018_LFQ_IT_3_C,,0.5165853929229371
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.4987463563782657
RB2022_3_RecoverySprint,,0.4151251107425258
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,0.4969480885719045
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.5523040770741638
CK2022_2 40-1,,0.534081468036573
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5418667234151383
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5053822028912709
AR2021_ALG 1 μM,,0.5055326618957569
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.4962888433340565
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5181551030316641
CK2022_9 16-1,,0.5021799733104116
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5152452490463307
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.49703170009132647
CK2022_16 16-1,,0.4863992741489549
FS2019_db/db3,,
CK2022_15 40-1,,0.5053825502288128
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5804393795707309
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5136239799762562
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5674166226826709
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.5358270447333681
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5233467089540741
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.5364274726208283
YA2020_Reporter_intensity_Normal_No.4,,0.5280165376968289
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4913875797737081
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.4851770652746172
RN2012_L13,,0.5930248431112132
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,0.4709893360070396
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,0.49447951620952635
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5242723311643331
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5031877086001652
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,0.5564240742180399
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5163568319183494
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5892905335295611
GF2025_P3_Adh,,0.5184366623890272
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5820238079321666
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.49556951487755413
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5496333051390723
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.4762909902164458
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,0.47615956962325884
YA2020_Reporter_intensity_Normal_No.3,,0.5281957616074481
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5616304300613542
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.5466863797414182
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5393385666868232
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.4391021320410693
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5053904665438411
CW2012_10 µM Erl/control Experiment 2 Replicate A,,0.4857555765612382
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,,0.5489182087247614
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.578263255205592
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,0.5154748746236454
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.5214309223326735
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5155519511326836
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.4839681907800446
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5259793670086096
RB2022_7_RecoveryEndurance,,0.5546823861412539
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5150249177493577
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.57388879545049
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.5263836050780396
CK2022_5 200-1,,0.5269695907345359
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.511040477834329
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,0.5280354267859513
AH2018_LFQ_2_C,,0.5656517169440701
AH2018_SILAC_MR_1_X,,0.5742936983215047
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.5155472298784954
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,0.5225676306800607
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5293434265024101
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5158209631043036
FSO2013_Ratio H/L normalized Rep3,,0.5134245598636822
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,0.5193250873374868
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,0.5006720998519839
AH2018_SILAC_IT_1_X,,0.4977321028576915
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.5094316343796631
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.48434063522912957
WZ2023_Pe_025_20min,,0.5872880250967463
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,0.42936977566665546
AH2018_LFQ_2_N,,0.567208061862365
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5894701704636492
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.587882585790884
SR2019_HCC1419_Biol_repl_4,,0.47945598267823314
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.4724102495571249
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.5179946321770741
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5411888095107209
WZ2023_Su_025_10min,,0.5844149969839189
AH2018_LFQ_IT_4_X,,0.5132514014491109
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.5783813848217609
CW2012_10 µM Gef/control Experiment 1 Replicate B,,0.4774899497731366
SFR2015_HL_log2_ratio_avg_a,,0.5363995688483031
CW2012_10 µM Erl/control Experiment 3 Replicate A,,0.49207316176644994
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.47533016535478256
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5252226666092529
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.4815124320885564
LY2019_P7+,,0.4775327105093136
EP2017_Untreated R#1 normalized log2 ratio,,0.4549715060803909
RN2012_L10,,
PG2020_Intensity 4h_C,,0.5096955230000487
EP2017_Mitotic R#3 normalized log2 ratio,,0.4675516373951363
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.4957747584415215
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,0.5457899527895717
CR2017_Ratio Replicate 1.1,,0.517181499721787
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5057551058418001
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.49599716723787424
GF2025_P9_Sph,,0.5188105330162931
CK2022_6 200-1,,0.5266904784035965
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5694245578389339
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.470407570117053
PG2020_Intensity 2h_D,,0.5029745428270683
EP2017_Untreated R#3 normalized log2 ratio,,0.5707764436137444
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.526053068156602
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.5047049572726526
RB2022_7_PostEndurance,,0.5308391380305243
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,0.49780621036116085
EP2017_Pervanadate R#2 normalized log2 ratio,,0.44849105360747127
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5167838856941239
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,0.502482839631866
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,0.5162615286009157
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.5394575648230754
AH2018_SILAC_MR_3_N,,0.5601260186792446
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,0.5113186419194484
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.5731023006432064
RB2022_2_PostStrength,,0.5533717822552178
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5192701669702987
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,0.5534965403443896
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.5571951138950139
CR2017_Ratio Replicate 2.3,,0.502443396987652
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.4931537388856122
YA2020_Reporter_intensity_Normal_No.2,,0.5344121260713041
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.5408266990189178
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5736681887302127
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.5177429509813675
RAM2015_Log2 B,,0.5249790814210981
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,0.4975263473216222
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.5148790189582851
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.5155583573049766
WZ2023_Su_025_30min,,0.5836320610731047
AH2018_LFQ_4_N,,0.5542656221975364
CR2017_Ratio Replicate 1.2,,0.5064652517373537
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5587927020689963
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.521694875815508
RB2022_7_PreEndurance,,0.5556654474025833
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5585110337550429
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5282961787039144
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.5281625296386876
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5707733555639324
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5694095573312641
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,0.48712827936912517
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.5654520847884766
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5249545314326607
RB2022_3_PostStrength,,0.5368853624524387
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5607218494320954
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5215479728450966
AH2018_LFQ_2_X,,0.5657391477488255
PG2020_Intensity 2h_B,,0.4928977679343289
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.5650234140613332
GF2025_P3_Sph,,0.5405998729209829
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5208630562096023
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5023201621099062
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,0.526213653612527
CR2017_Ratio Replicate 2.4,,0.4873016818238191
ZQ2022_N1,,
LY2019_P6-,,0.5667926132386528
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.5049488007027226
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,0.5646978479764194
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.5098203971783462
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,0.4975011018776341
CK2022_7 40-1,,0.5270172462721439
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5289604246097249
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,0.4891485293557983
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.5800606184973573
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.4863089245207519
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,0.4706638152146718
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5059198002200274
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5092994836860556
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.5109120755719182
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,0.48587169794052804
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.5399454629577661
AH2018_SILAC_MR_3_C,,0.5354983905630709
AH2018_LFQ_M_4_C,,0.5562521377052617
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.46135342390565626
CK2022_6 40-1,,0.5280504859151399
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.5094196131789653
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.592988088554004
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.48770647283388885
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.58934322446422
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,0.4824633268943916
GF2025_P10_Adh,,0.5197656469180315
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,0.48731893578236524
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5886186613120754
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5683046235535224
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.5368523405014288
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5242608962304942
LY2019_P8+,,0.5102328108087302
RB2022_2_RecoveryEndurance,,0.562089638982096
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5338372996426198
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.54798553501545
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5050306541305699
LY2019_P2-,,0.533519755425825
AH2018_LFQ_IT_1_X,,0.5206976124038193
JJ2018_Ratio H/L normalized pP3___1,,0.49758882187959835
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,0.5919067894362297
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,0.5245291504734544
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5345655887758477
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5041227587876921
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,0.46909247802691906
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,0.5723749766010972
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5616621777235226
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.47358754382701956
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.5823267571784394
KS2014_Intensity C2,,0.5935403062935127
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.5235622982818552
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5282442915592244
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.48350874571982355
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.5039722244419038
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5558222371142426
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.4557822676308693
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5830744849438864
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.47614677904640584
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5308840871697442
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5138813278255746
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,0.4978262160000481
AH2018_SILAC_MR_2_C,,0.5651720789534465
LATM2013_Log2 Ratio (Medium/Light) Forward,,0.47678488357434756
PG2020_Intensity 2h_A,,0.506776010206638
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5689501722835618
JJ2018_Ratio H/M normalized___1,,0.4773012306589232
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.556454401706342
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.5616777841800221
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.5923971718148165
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5725338857639332
AH2018_LFQ_IT_4_N,,0.5147541483704895
CK2022_15 200-1,,0.5111617437539682
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,0.47766774014235525
JJ2018_Ratio M/L normalized pP3___1,,0.5075731963815667
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5157397008901855
LATM2013_Log2 Ratio (Light/Medium) Reverse,,0.5460555870773615
CK2022_2 200-1,,0.5400880330523109
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.5821397843694961
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.4574963334710856
EP2017_Pervanadate R#1 normalized log2 ratio,,0.47657898614043415
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5470185950562
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,0.5921114309846562
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,0.5626945461547409
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.5781067984834481
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.5164776163014018
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5175950177678375
AH2018_SILAC_M_2_X,,0.5117043831346119
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.5831962158895847
PG2020_Intensity 6h_C,,0.507799819647231
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,0.5158648980706629
JJ2018_Ratio M/L normalized pP1___1,,0.5258047005470758
AH2018_LFQ_M_3_N,,0.5707658139428938
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.588694830825795
CK2022_15 16-1,,0.4926105884980605
CK2022_3 16-1,,0.5177607268260375
LY2019_P4-,,0.5112549592008241
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5357994303511531
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.4837302521469948
CK2022_10 16-1,,0.5126403737240229
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.5039671400041348
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.49935033463572465
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.490608987586507
CF2017_EOC 2,,
RB2022_6_PostEndurance,,0.5372680305637799
AH2018_SILAC_1_N,,0.5225854069462951
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.49474142788852565
RB2022_7_PreSprint,,0.5468685459815875
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.5057260878482361
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,0.4999644345700343
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5909076489421271
AR2021_L41 1 μM,,0.4999205088575862
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5854108625095708
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,0.5419303729589527
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,0.5693439199337893
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5750812417222964
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5412113958346595
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5253297223283409
WZ2023_Pu_025_10min,,0.5906926682354076
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.4842808172756732
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,0.49142096950949066
WZ2023_Pe_010_30min,,0.5916040409010425
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5139362245276592
KS2014_Intensity C6,,0.5576565197966951
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5050300004651175
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,0.4684656178076277
CK2022_16 40-1,,0.5038922683224071
AH2018_SILAC_IT_2_C,,0.5237004979983086
CK2022_5 40-1,,0.5273293449457982
AH2018_LFQ_3_X,,0.5598967862253748
UK2020_UA_3,,0.5082308523295638
LY2019_P7-,,0.5018435007370265
GF2025_P5_Adh,,0.4478045942917386
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5136860910686042
SR2019_HCC1954_Biol_repl_3,,0.4758434097796737
CR2017_Ratio Replicate 2.2,,0.5146974760226734
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5063724258789041
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.49602192161100805
PG2020_Intensity CT_B,,0.5036264143138838
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5570976711051125
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5685230184087969
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5662849141794836
YA2020_Reporter_intensity_Cancer_No.4,,0.5425077145595703
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.4811770345730589
RB2022_2_PreEndurance,,0.5524447514323988
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,0.5195018266394463
FR2021_Intensity.H,,
CK2022_14 16-1,,0.4933578609120339
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.4854161594048804
AH2018_TMTMS2_1_X,,0.5865385549530147
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5116866778316639
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5206586766483343
PG2020_Intensity 10h_B,,0.49522769062224214
AH2018_TMTMS3_1_X,,0.5682634422213624
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.49782614612586223
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.43842855404767817
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5055434648341544
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.44735374971059244
AS2011_Ratio H/L Normalized RNAi_2_1,,
